INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹47 Cr | ₹114 Cr | ₹-430 Cr | ₹370 Cr | ₹16 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDEGENE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹114 Cr |
| Mar2023 | ₹-430 Cr |
| Mar2022 | ₹370 Cr |
| Mar2021 | ₹16 Cr |
How is Net Cash Inflow / Outflow of INDEGENE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹47 Cr | -59.14 | |
| Mar2024 | ₹114 Cr | Positive | |
| Mar2023 | ₹-430 Cr | Negative | |
| Mar2022 | ₹370 Cr | 2,174.92 | |
| Mar2021 | ₹16 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹12,160.4 Cr | -2.7% | -4.1% | -16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -2.7% |
-4.1% |
-16.9% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses